top of page
NC.jpg

IN THE STATES

NORTH CAROLINA

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in North Carolina in 2022.

NC.png

Economic
Output

$80.2B

Direct Jobs Supported by the Industry

56,183

Total Jobs Supported

226,487

State Total Vendor Relationships

2,514

State Total Vendor Spending

$5,728,340,924

Clinical
Trials

1,196

Investments at Clinical Trial Sites

$648.6M

Clinical Trial Participants

42,279

Total Economic Impact of Clinical Trial Sites

$1.80B

bottom of page